| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Atara Biotherapeutics, Inc. (ATRA) has 3 insiders with recent SEC Form 4 filings, including 1 buy and 23 sells. ATRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.32M | $14.28M | - | |
| CEO | 143.1K | $1.54M | - | |
| Other | 52.0K | $561.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2016 | Gallagher Carol Giltner | Director | Sale+OE | 1,183 | $16.30 | $19,282.90 | -1.2% | |
| Feb 17, 2016 | Soffer Gad | Chief Operating Officer | Sale+OE | 5,711 | $16.77 | $95,785.75 | -2.1% | |
| Feb 16, 2016 | Clark Mitchall G. | Chief R &Qa Officer | Sale+OE | 4,153 | $15.35 | $63,748.55 | -4.9% | |
| Feb 16, 2016 | Haqq Christopher | Chief Medical Officer | Sale+OE | 3,208 | $15.43 | $49,499.44 | -1.1% | |
| Feb 16, 2016 | McGrath John | Chief Financial Officer | Sale+OE | 6,000 | $15.49 | $92,940.00 | -6.7% | |
| Jan 14, 2016 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 2,400 | $20.20 | $48,468.00 | -0.3% | |
| Dec 31, 2015 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 2,400 | $26.00 | $62,388.00 | -0.2% | |
| Dec 16, 2015 | Dobmeier Eric | Director | Buy | 2,500 | $22.00 | $55,000.00 | New | |
| Dec 15, 2015 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 2,400 | $22.46 | $53,908.00 | - | |
| Dec 4, 2015 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 4,000 | $37.45 | $149,780.00 | -0.2% |